SCHEMBL30103066

SCHEMBL30103066

COc1cc(-c2ccc(Cn3ncc4cc(Cl)cc(C(=O)O)c43)cn2)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 5/20 0.40
ALKBH1 Q13686 1/20 0.40
GRIN2B Q13224 2/20 0.39
GRIN1 Q05586 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
KDM1A O60341 1/20 0.39
KDM4E B2RXH2 2/20 0.39
GRM2 Q14416 1/20 0.38
AVPR1B P47901 2/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
TP53 P04637 2/20 0.36
MDM2 Q00987 2/20 0.36
ROCK2 O75116 1/20 0.36
GRK2 P25098 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30103081 0.94 BRD4 (0.40) CACNA1HALKBH1KDM4EGRM2MEN1
SCHEMBL24785847 0.94 BRD4 (0.40) CACNA1HALKBH1KDM4EGRM2MEN1
SCHEMBL30103022 0.92 CACNA1H (0.41) CACNA1HGRIN2BGRIN1PDE4APDE4B
SCHEMBL30103094 0.89 ALKBH1 (0.41) CACNA1HALKBH1GRIN2BGRIN1PDE4A
SCHEMBL24785076 0.89 ALKBH1 (0.41) CACNA1HALKBH1GRIN2BGRIN1PDE4A
SCHEMBL24785825 0.88 KDM4E (0.39) CACNA1HALKBH1GRIN2BGRIN1KDM1A
SCHEMBL30103031 0.88 KDM4E (0.39) CACNA1HALKBH1GRIN2BGRIN1KDM1A
SCHEMBL24785851 0.86 KDM1A (0.41) CACNA1HGRIN2BGRIN1PDE4APDE4B
SCHEMBL30103083 0.86 BRD4 (0.41) CACNA1HGRM2MEN1KMT2AROCK2
SCHEMBL24785849 0.85 BRD4 (0.42) CACNA1HGRM2ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448913-A Bicyclic compounds for the treatment of EP2, EP4 receptor mediated diseases 武汉人福创新药物研发中心有限公司 2022-12-09 CN disclosed